Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × NIH × CMF regimen × Clear all

Phase

Status

Completed 6 Unknown 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 15 Biopsy 9 Magnetic Resonance Spectroscopy 7 Cyclophosphamide 5 Vincristine 4 Doxorubicin 4 X-Rays 3 Prednisone 3 trastuzumab deruxtecan 2 prednylidene 2 deltacortene 2 decitabine and cedazuridine drug combination 2 Temozolomide 2 Rituximab 2 Radiotherapy 2 Nivolumab 2 Lenalidomide 2 Ipilimumab 2 CTLA-4 Antigen 2 Actinium 2 venetoclax 1 selinexor 1 sargramostim 1 polatuzumab vedotin 1 obeticholic acid 1 neratinib 1 ipatasertib 1 fludarabine phosphate 1 durvalumab 1 ceralasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡